ZBiotics
New accelerator entry · 2017-11-18 · the record
ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications.
ZBiotics is a Y Combinator company in the Winter 2018 batch. Its directory entry describes it as: ZBiotics makes genetically engineered probiotics. The founder listed is Stephen Lamb (Founder) (Y Combinator directory entry, November 18, 2017).
Sell to companies like ZBiotics? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2017-11-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ZBiotics.
Free to see. No signup.
More on ZBiotics and the records around it.
Same batch, Healthcare first.
Get an email when ZBiotics changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ZBiotics raises, hires or launches. No email unless you switch it on.
Watch ZBiotics →Get the full cited report on ZBiotics
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on ZBiotics: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
ZBiotics is a synthetic biology company founded in 2016 and headquartered in San Francisco, California. The company bioengineers probiotic bacteria for nutraceutical and other applications. They launched the world's first genetically engineered probiotic in 2019 – a probiotic that breaks down a toxic byproduct of alcohol. They are currently developing a pipeline of additional engineered probiotics for other consumer health applications.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on ZBiotics: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ZBiotics covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ZBioticsYou get an alert in MentionFox the next time this company shows up.
If you're behind ZBiotics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for ZBiotics. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.

https://mentionfox.com/funding/yc-zbiotics